Companies: 49,246 Total Market Cap: 132386205533959.40

Revenio Group Oyj

HEL-REG1V
Healthcare Medical Devices
Rank #10114
Market Cap 865.38 M
Volume 12,807
Price 32.42
Change (%) 0.35%
Country or region Finland Finland

Revenio Group Oyj's latest marketcap:

865.38 M

As of 05/20/2025, Revenio Group Oyj's market capitalization has reached $865.38 M. According to our data, Revenio Group Oyj is the 10114th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 865.38 M
Revenue (ttm) 119.90 M
Net Income (ttm) 21.54 M
Shares Out 26.60 M
EPS (ttm) 0.81
Forward PE 31.78
Ex-Dividend Date 04/11/2025
Earnings Date 04/29/2025
Market Cap Chart
Data Updated: 05/20/2025

Revenio Group Oyj's yearly market capitalization.

Revenio Group Oyj has seen its market value drop from €1.33 B to €767.38 M since 2020, representing a total decrease of 42.49% and an annual compound decline rate (CAGR) of 11.84%.
Date Market Cap Change (%)
05/20/2025 €767.38 M 9.68%
12/30/2024 €706.92 M -2.12%
12/29/2023 €722.26 M -29.6%
12/30/2022 €1.03 B -30.47%
12/30/2021 €1.48 B 10.59%
12/30/2020 €1.33 B

Company Profile

About Revenio Group Oyj

Revenio Group Oyj specializes in ophthalmological devices and software solutions for diagnosing conditions such as glaucoma, macular degeneration, and diabetic retinopathy. The company operates in the United States, Finland, and internationally.

Product Portfolio

  • iCare Tonometers: Includes IC100, IC200, ST500, TONOVET Pro, and TONOVET Plus for intraocular pressure measurement.
  • iCare HOME2: A home-use intraocular pressure monitor.
  • iCare Sensors: Accessories for hygienic and painless IOP measurement.
  • Fundus Imaging Systems: iCare EIDON AF, EIDON, and EIDON UWF F for retinal imaging.
  • iCare COMPASS: A device for visual field examination and confocal fundus imaging.
  • iCare ILLUME: AI-powered early detection for diabetic retinopathy, macular degeneration, and glaucoma.
  • iCare CLINIC: Cloud-based service for IOP data storage and analysis.
  • Oculo: An eye care software platform integrating telehealth, remote monitoring, and analytics.

Company Background

Founded in 2001, Revenio Group Oyj is headquartered in Vantaa, Finland.

Frequently Asked Questions

As of 05/20/2025, Revenio Group Oyj (including the parent company, if applicable) has an estimated market capitalization of $865.38 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Revenio Group Oyj global market capitalization ranking is approximately 10114 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Finland
Founded 2001
IPO Date n/a
Employees 241
CEO Jouni Toijala
Sector Healthcare
Industry Medical Devices
Address Aeyritie 22
Vantaa, 01510
Finland
Website https://www.reveniogroup.fi
People Also Watch
ABT
134.67 0.35%
BSX
105.95 0.35%
Stryker
388.68 0.35%
Medtronic plc
86.18 0.35%